Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool
Clinical trial NCT01699711 · COMPLETED
Trial details
- NCT number
- NCT01699711
- Sponsor
- Parc de Salut Mar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-06-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.